Acute CBD treatment reversed the heightened dopamine neuron activity seen in both male and female MAM rats and improved memory deficits in males, supporting CBD's potential antipsychotic-like effects.
Psychosis researchers, psychiatrists interested in CBD therapeutics, and neuroscientists studying dopamine regulation.
CBD normalized VTA dopamine neuron overactivity in both sexes
What the researchers found
Both male and female MAM rats showed increased VTA dopamine neuron population activity, which was reversed by CBD (60 mg/kg) in both sexes. CBD also reversed memory impairment in male MAM rats, while females showed no memory deficits to reverse.
Why it matters
Current antipsychotics primarily block dopamine D2 receptors with significant side effects. CBD's ability to normalize dopamine system activity through a different mechanism supports it as a potential alternative.
The numbers in context
CBD: 60 mg/kg. Both sexes showed increased VTA DA activity (reversed by CBD). Male MAM rats had NOR deficits (reversed by CBD). Female MAM rats had no NOR deficits. Anxiety in EPM not reversed by CBD.
How the study worked
MAM model: pregnant rats received MAM or saline on GD17. Adult offspring tested on EPM, NOR, MK-801 locomotor response. In vivo electrophysiology of VTA DA neurons. CBD (60 mg/kg) given 1 hour before each test.
What this study cannot tell us
MAM model captures some but not all schizophrenia features. Acute treatment only. Sex differences complicate interpretation. Animal behavior does not directly translate to human psychosis.
How to read the evidence
Rigorous electrophysiology combined with behavioral testing in a validated model, limited by acute dosing and animal-to-human translation.
When this study was published
Published in 2025.
The bigger picture
Finding that CBD normalizes the upstream dopamine system activity that drives psychotic symptoms offers a fundamentally different therapeutic approach from current D2 blockers.
Questions still open
- Would chronic CBD treatment maintain these effects? Why do female MAM rats not show memory deficits?
Common questions
Could CBD treat schizophrenia?
Does CBD work differently in males and females?
Read the original research
Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.
Schizophrenia research, 286, 63-73
Citation
Fabris, Débora; Andrade, Lídia M; Freitas, Ícaro Silva; Gomes, Felipe V; Guimarães, Francisco S. (2025). Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.. Schizophrenia research, 286, 63-73. https://doi.org/10.1016/j.schres.2025.10.012
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk